I Didn’t Set Out to Build a Company So, here is my story. You see, when I started this journey, I wasn’t trying to build a startup. that was not in my mind. I am retired and live simple... no tension and no endless business meetings. I just wanted to code an engine with modern tools. I wasn’t chasing venture capital. I wasn’t thinking about pricing tiers, TAM, or business plans. Shoot! I am not even good at writing a business plan. I had a much simpler and much harder goal: I

Happy New Year 2026 After 6 weeks of focused work, I successfully deployed a production-grade molecular docking pipeline  (AutoDock Vina + RDKit/OpenMM stack) to Google Cloud Run , backed by Google Cloud Storage  and exposed through a clean API. This is a must-have for anyone who needs to dock compounds at scale without GPUs or Enterprise Hardware, or who uses Kubernetes and/or a DevOps team! Yes, this was built without : A DevOps team Kubernetes Persistent VMs GPUs Enterpris

As of today, I have quietly moved 478,808 virtual Compounds through a quantum-enhanced drug discovery machine in my back office in Oklahoma. Today I hit a nice milestone on the Citizen Scientist  page of QuantumCURE Pro™  and the numbers made me smile, so I’m sharing them. The Raw Numbers Compounds processed (Citizen Scientist):  478,808 Compounds that made it into the Golden List:  30 Hit rate: What does that mean? In industry, typical virtual screening or HTS hit rates ar

QuantumCURE Pro ™ screen shots - Round two of QuantumCURE pro™ software validation is officially in the books. Some people pick up fishing or golf in retirement. I enjoy those too, but for the last few years I’ve been teaching myself quantum computing, cheminformatics, and how to build full cancer drug discovery portals. Why? People ask me that a lot. My answer is simple: why not? I want to be useful, and I still have work to do. I sit in a cold Oklahoma garage, lift heavy

I saw an MIT study tonight about AI and job losses, and that is alarming. So,  AI can already replace % 11. 7% of US jobs....and workforce, but what the MIT “11.7%” really is: So, MIT + Oak Ridge built a model called the Iceberg Index  that looks at: 151M U.S. workers 900+ occupations 32,000+ skills They asked: “With AI that exists today , what fraction of current work tasks could AI technically do?” Their answer: AI is already capable of doing tasks equal to 11.7% of tot

So, I have created a nifty molecular docking engine that can stand shoulder-to-shoulder with big-pharma platforms that cost $100K per year per license. Ok, I admit I don’t have the pedigree of a 20-year vendor track record, and I’m not a biologist, but I am  very good at building complex systems and making them actually run in the real world. For the past 30 years, I’ve shipped and operated mission-critical software for video, networking, and now quantum-enhanced simulation.

Companies like Schrödinger and Atomwise have incredible platforms, but their primary business is selling software and partnering with major pharmaceutical companies. They provide powerful tools  and co-discovery services; their partners own most of the downstream pipeline and wet-lab risk. Schrödinger+1 I built QuantumCURE  with a different mission: not just to rank molecules, but to actually walk a set of compounds all the way into a wet list I own and can defend . In less t

QuantumCURE Fellowship Program Over the past year, I’ve invested more than 3,000 hours  building QuantumCURE Pro  — a platform that brings quantum entropy into drug discovery. My mission is simple: to be useful to humanity  and help accelerate the search for life-saving cancer treatments. Using scientifically validated tools, I’m screening millions of compounds from PubChem with multiple entropy sources, quantum annealing , photonic QRNG seeds , and classical PRNGs . The syst

By Mansour Ansari — Founder, QuantumLaso LLC I’ve been really busy these days. Not bad for a retired software engineer who officially...

High Performance Molecular Docking System - Citizen Scientist system And yes — I am actively searching for a viable cancer drug lead, with a better chance than most traditional approaches, because my system explores chemical spaces that classical methods often overlook. It’s been almost a year in the making. So far, oh, about 3,340 hours since November 2024. My journey started before that, learning and researching, and that goes back to the COVID-19 era. Built not by a pharm

Version 5 QuantumCURE Pro, Citizen Scientist Desktop and mobile versions --- Breaking Into New Chemical Space I'm excited to announce QuantumCURE v5, the latest and most advanced release of our quantum-powered drug discovery platform. For the first time, QuantumCURE now integrates Bemis–Murcko scaffolding — a powerful computational chemistry technique developed by Guy Bemis and Mark Murcko . This method reduces each compound to its core structural framework, stripping away si

Hey! You might be wondering — what’s really going on under the hood in the QuantumCURE software I’ve been building? What am I actually doing here? And honestly, what the hell is molecular docking anyway? First things first: if you scroll down and read my disclaimer, you’ll know exactly what I’m not  doing. I’m not a chemist. I’m not a physicist. I don’t work for big pharma. What I am  is a passionate software and systems designer. I understand the moving parts of drug discove

Molecular Docking Software Design from a Computer Programmer’s Perspective It took me 7-8 months to build a working drug discovery system...

choose Compound Count After months of tense work, countless late nights interacting with my “farm” of computers, and real quantum hardware (USB and PCIe QRNG devices), I’ve built something rare: a fully functional, quantum-assisted drug discovery infrastructure . We’re talking: AutoDock Vina containers Automated protein preparation orchestration GCS (Google Cloud Storage) workflows Cloud-run ready pipelines This isn’t a “simulation of a simulation.” This is production-grade c